| Product Code: ETC13371209 | Publication Date: Apr 2025 | Updated Date: Aug 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
| Market Size (2025) | USD 1.3 Billion |
| Forecast Size (2032) | USD 2.1 Billion |
| CAGR | 7.90% |
| Base Year | 2025 |
| Forecast Period | 2026-2032 |
| Largest Region | North America |
| Fastest Growing Region | Asia |
| Largest Segment | Contract Research |
| Fastest Growing Segment | Contract Manufacturing |
| Leading Companies | Covance, Charles River Labs, IDEXX Laboratories, Eurofins, Synergy Biomedical |

The Global Veterinary CRO CDMO Market was estimated at USD 1.3 Billion in 2025 and is projected to reach USD 2.1 Billion by 2032, growing at a CAGR of 7.90% from 2026 to 2032.
The Global Veterinary CRO CDMO Market is undergoing significant transformation, driven by an increasing emphasis on specialized veterinary pharmaceutical services. Recent growth in pet ownership has enhanced the necessity for robust research and development activities, pushing organizations to adopt outsourcing strategies with contracted service providers.
This market holds substantial importance for the broader healthcare landscape, particularly as life sciences firms pivot towards personalized animal medications. As healthcare paradigms shift, the demand for manufacturing and clinical trials tailored to unique veterinary drug profiles is becoming crucial, distinguishing this market from adjacent sectors.
This graph illustrates the annual growth rates of the Global Veterinary CRO CDMO Market from 2022 to 2032, highlighting a steady upward trajectory and projected expansion over the forecast period.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate (%) | Major Drivers |
| 2022 | 6.62 | Manufacturers faced rising raw material costs impacting the veterinary CRO CDMO sector. |
| 2023 | 8.32 | Enhancing sustainability within hospital infrastructure promotes eco-friendly veterinary CRO practices. |
| 2024 | 8.54 | While regulatory changes streamline FDA approvals, the veterinary CRO CDMO market gains traction. |
| 2025 | 5.69 | Increased competition among veterinary CRO CDMO companies accelerates service diversification and innovation. |
| 2026 | 7.35 | Veterinary healthcare providers are adopting advanced drug delivery systems for improved clinical outcomes. |
| 2027 | 5.63 | Wearable monitoring devices are optimizing supply chain dynamics for veterinary drug distribution. |
| 2028 | 7.41 | Regional veterinary CRO CDMO firms are expanding their services across emerging markets in Asia. |
| 2029 | 8.79 | A shift toward digital therapeutics enhances patient outcomes data collection in veterinary services. |
| 2030 | 7.74 | In North America, increased investment in veterinary CRO CDMO drives innovation through M&A activity. |
| 2031 | 6.86 | Advanced diagnostic imaging techniques are reshaping workforce training in the veterinary CRO CDMO sector. |
| 2032 | 5.89 | As pet ownership rises, veterinary CRO CDMO companies adapt services to meet evolving client needs. |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary research methodology, combining internal industry data, secondary research, and primary validation, updated periodically to reflect current market conditions. As markets evolve rapidly, figures for certain industries may vary slightly and are intended as informed estimates rather than absolute figures. For the most current market sizing, we recommend validating figures with a 6Wresearch analyst.
Below are some of the specific key takeaways from the market, including:
The Global Veterinary CRO CDMO Market faces several constraints, including stringent regulatory frameworks. For instance, clinical trial approvals require adherence to guidelines set by the FDA and EMA, which can prolong development timelines and incur additional costs, often exceeding $2 million per trial. In addition, many players encounter difficulties sourcing qualified personnel with dual expertise in veterinary medicine and research methodologies, limiting operational efficiency and innovation.
A notable trend within the Global Veterinary CRO CDMO market is the increasing integration of digital technologies, such as AI and machine learning, in drug development processes. For example, Charles River Labs has implemented AI algorithms to analyze large datasets, significantly reducing the time to market for new veterinary drugs. Moreover, the shift towards personalized animal care is driving demand for custom formulations, prompting CDMO providers to adapt their services accordingly.
Another transformation is the heightened focus on sustainability in manufacturing practices. Veterinary CRO CDMOs are exploring biomanufacturing and eco-friendly raw material sourcing, aligning with global trends towards sustainability across various sectors. Innovations in this area not only cater to consumer preferences but also enhance regulatory compliance in multiple jurisdictions.
The Global Veterinary CRO CDMO market is ripe with lucrative opportunities. One promising area is the development of biopharmaceuticals tailored for livestock, significantly driven by the increasing necessity to improve animal health and productivity. Companies like Eurofins have announced investments nearing $50 million in new facilities dedicated to research in this sector, aiming to capitalize on the growing demand for effective treatments.
Additionally, advancements in genetically engineered vaccines for companion animals represent an emerging revenue stream, projected to capture a rising share of the market. As the shift toward advanced therapeutic solutions increases, companies holding expertise in genomic technology stand to benefit greatly from partnerships with CROs for research and development.
Contract Research is the leading service type in the Global Veterinary CRO CDMO Market, holding an approximate 60% share in 2025. This dominance is attributed to the high necessity for extensive testing, regulatory compliance, and clinical trials, making this segment critical for drug development. Meanwhile, Contract Manufacturing is forecasted to be the fastest-growing segment, with a CAGR of 10.5% from 2026 to 2032, as businesses increasingly look to outsource production to enhance efficiency and reduce costs.
Preclinical drug development is the largest segment within the Global Veterinary CRO CDMO Market, accounting for approximately 70% share in 2025. This substantial share can be attributed to the rigorous testing protocols required before moving to commercial stages. Conversely, Commercialization is anticipated to grow rapidly, with a CAGR of 9.8% from 2026 to 2032, driven by the increasing cost of chronic disease management in pets and livestock.
Companion Animals constitute the largest segment in the Global Veterinary CRO CDMO Market, commanding roughly 65% share in 2025. This popularity is propelled by the growing pet ownership trend and the elevated expenses related to animal healthcare. In contrast, Livestock is expected to showcase the fastest growth, with a projected CAGR of 9.2% from 2026 to 2032, driven by increasing interest in improving animal wellness and productivity through advanced veterinary medications.
Vaccine Production leads the Global Veterinary CRO CDMO Market, accounting for an estimated 55% share in 2025, thanks to rising global vaccination initiatives and veterinary health awareness. Drug Testing is the fastest-growing application, predicted to achieve a CAGR of 9.5% from 2026 to 2032, as regulations tighten and the demand for quality assurance in pharmaceutical products rises substantially.
Pharmaceutical Companies represent the largest segment in the Global Veterinary CRO CDMO Market, capturing about 75% share in 2025, owing to their established manufacturing capabilities and extensive research networks. Biotech Firms are anticipated to see the fastest growth, with a projected CAGR of 10.0% from 2026 to 2032, incentivized by increased research funding and a growing focus on specialized veterinary therapeutics.
North America is the largest region in the Global Veterinary CRO CDMO Market, holding approximately 48% share in 2025, facilitated by advanced infrastructures and high levels of investment in animal health. In contrast, Asia is identified as the fastest-growing region, expected to record a CAGR of 9.0% from 2026 to 2032, attributed to increasing pet ownership and evolving regulatory frameworks that are boosting the demand for veterinary products.
The regulatory landscape for the Global Veterinary CRO CDMO Market is largely shaped by various government initiatives aimed at enhancing animal health and safety standards. These policies not only influence research funding but also dictate production practices to ensure compliance with safety protocols.
The trajectory of the Global Veterinary CRO CDMO Market reflects deeper integration of advanced technologies into service offerings. For instance, companies are increasingly investing in artificial intelligence and data analytics solutions to enhance drug development efficiencies. This integration is projected to accelerate the timeline and reduce costs associated with clinical trials, shifting traditional models toward more adaptive frameworks. As veterinary drug developers adapt to personalized treatment approaches, this market is expected to pivot towards specialized services and streamlined operations, significantly impacting competitive dynamics through 2032.
Recent advancements in the Global Veterinary CRO CDMO market highlight key strategic movements by leading players aimed at improving service capabilities and operational efficiencies. These developments are crucial for maintaining competitiveness in a rapidly evolving landscape.
The competitive structure of the Global Veterinary CRO CDMO Market is characterized by a blend of major players, each with distinct strengths and strategic focuses. This market is becoming more consolidated as companies strive for comprehensive service offerings, and partnerships between CROs and biotechnology firms are increasingly common, enhancing resource sharing and innovation.
| Leading Company | Core Strength | Strategic Focus |
|---|---|---|
| Covance | Integrated capabilities in research and clinical trials | Expansion in North America and Asia |
| Charles River Labs | Leading provider of preclinical and clinical support | Digital tool integration for efficiency |
| IDEXX Laboratories | Expertise in diagnostic testing for pets | Strategic acquisitions to enhance service range |
| Eurofins | Strong focus on biomanufacturing | Capacity building for contract manufacturing |
| Synergy Biomedical | Specialization in regenerative medicine | Research partnerships in veterinary therapeutics |
Each company is strategically positioning itself to leverage emerging opportunities, ensuring their relevance in a transforming market landscape.
Global Veterinary CRO CDMO Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Veterinary CRO CDMO Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Veterinary CRO CDMO Market Revenues & Volume, 2022 & 2032F |
3.3 Global Veterinary CRO CDMO Market - Industry Life Cycle |
3.4 Global Veterinary CRO CDMO Market - Porter's Five Forces |
3.5 Global Veterinary CRO CDMO Market Revenues & Volume Share, By Regions, 2022 & 2032F |
3.6 Global Veterinary CRO CDMO Market Revenues & Volume Share, By Service Type, 2022 & 2032F |
3.7 Global Veterinary CRO CDMO Market Revenues & Volume Share, By Drug Development Stage, 2022 & 2032F |
3.8 Global Veterinary CRO CDMO Market Revenues & Volume Share, By Animal Type, 2022 & 2032F |
3.9 Global Veterinary CRO CDMO Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.10 Global Veterinary CRO CDMO Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Global Veterinary CRO CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Veterinary CRO CDMO Market Trends |
6 Global Veterinary CRO CDMO Market, 2022-2032 |
6.1 Global Veterinary CRO CDMO Market, Revenues & Volume, By Service Type, 2022-2032 |
6.1.1 Overview & Analysis |
6.1.2 Global Veterinary CRO CDMO Market, Revenues & Volume, By Contract Research, 2022-2032 |
6.1.3 Global Veterinary CRO CDMO Market, Revenues & Volume, By Contract Manufacturing, 2022-2032 |
6.2 Global Veterinary CRO CDMO Market, Revenues & Volume, By Drug Development Stage, 2022-2032 |
6.2.1 Overview & Analysis |
6.2.2 Global Veterinary CRO CDMO Market, Revenues & Volume, By Preclinical, 2022-2032 |
6.2.3 Global Veterinary CRO CDMO Market, Revenues & Volume, By Commercialization, 2022-2032 |
6.3 Global Veterinary CRO CDMO Market, Revenues & Volume, By Animal Type, 2022-2032 |
6.3.1 Overview & Analysis |
6.3.2 Global Veterinary CRO CDMO Market, Revenues & Volume, By Companion Animals, 2022-2032 |
6.3.3 Global Veterinary CRO CDMO Market, Revenues & Volume, By Livestock, 2022-2032 |
6.4 Global Veterinary CRO CDMO Market, Revenues & Volume, By Application, 2022-2032 |
6.4.1 Overview & Analysis |
6.4.2 Global Veterinary CRO CDMO Market, Revenues & Volume, By Drug Testing, 2022-2032 |
6.4.3 Global Veterinary CRO CDMO Market, Revenues & Volume, By Vaccine Production, 2022-2032 |
6.5 Global Veterinary CRO CDMO Market, Revenues & Volume, By End User, 2022-2032 |
6.5.1 Overview & Analysis |
6.5.2 Global Veterinary CRO CDMO Market, Revenues & Volume, By Pharmaceutical Companies, 2022-2032 |
6.5.3 Global Veterinary CRO CDMO Market, Revenues & Volume, By Biotech Firms, 2022-2032 |
7 North America Veterinary CRO CDMO Market, Overview & Analysis |
7.1 North America Veterinary CRO CDMO Market Revenues & Volume, 2022-2032 |
7.2 North America Veterinary CRO CDMO Market, Revenues & Volume, By Countries, 2022-2032 |
7.2.1 United States (US) Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
7.2.2 Canada Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
7.2.3 Rest of North America Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
7.3 North America Veterinary CRO CDMO Market, Revenues & Volume, By Service Type, 2022-2032 |
7.4 North America Veterinary CRO CDMO Market, Revenues & Volume, By Drug Development Stage, 2022-2032 |
7.5 North America Veterinary CRO CDMO Market, Revenues & Volume, By Animal Type, 2022-2032 |
7.6 North America Veterinary CRO CDMO Market, Revenues & Volume, By Application, 2022-2032 |
7.7 North America Veterinary CRO CDMO Market, Revenues & Volume, By End User, 2022-2032 |
8 Latin America (LATAM) Veterinary CRO CDMO Market, Overview & Analysis |
8.1 Latin America (LATAM) Veterinary CRO CDMO Market Revenues & Volume, 2022-2032 |
8.2 Latin America (LATAM) Veterinary CRO CDMO Market, Revenues & Volume, By Countries, 2022-2032 |
8.2.1 Brazil Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
8.2.2 Mexico Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
8.2.3 Argentina Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
8.2.4 Rest of LATAM Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
8.3 Latin America (LATAM) Veterinary CRO CDMO Market, Revenues & Volume, By Service Type, 2022-2032 |
8.4 Latin America (LATAM) Veterinary CRO CDMO Market, Revenues & Volume, By Drug Development Stage, 2022-2032 |
8.5 Latin America (LATAM) Veterinary CRO CDMO Market, Revenues & Volume, By Animal Type, 2022-2032 |
8.6 Latin America (LATAM) Veterinary CRO CDMO Market, Revenues & Volume, By Application, 2022-2032 |
8.7 Latin America (LATAM) Veterinary CRO CDMO Market, Revenues & Volume, By End User, 2022-2032 |
9 Asia Veterinary CRO CDMO Market, Overview & Analysis |
9.1 Asia Veterinary CRO CDMO Market Revenues & Volume, 2022-2032 |
9.2 Asia Veterinary CRO CDMO Market, Revenues & Volume, By Countries, 2022-2032 |
9.2.1 India Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
9.2.2 China Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
9.2.3 Japan Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
9.2.4 Rest of Asia Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
9.3 Asia Veterinary CRO CDMO Market, Revenues & Volume, By Service Type, 2022-2032 |
9.4 Asia Veterinary CRO CDMO Market, Revenues & Volume, By Drug Development Stage, 2022-2032 |
9.5 Asia Veterinary CRO CDMO Market, Revenues & Volume, By Animal Type, 2022-2032 |
9.6 Asia Veterinary CRO CDMO Market, Revenues & Volume, By Application, 2022-2032 |
9.7 Asia Veterinary CRO CDMO Market, Revenues & Volume, By End User, 2022-2032 |
10 Africa Veterinary CRO CDMO Market, Overview & Analysis |
10.1 Africa Veterinary CRO CDMO Market Revenues & Volume, 2022-2032 |
10.2 Africa Veterinary CRO CDMO Market, Revenues & Volume, By Countries, 2022-2032 |
10.2.1 South Africa Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
10.2.2 Egypt Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
10.2.3 Nigeria Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
10.2.4 Rest of Africa Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
10.3 Africa Veterinary CRO CDMO Market, Revenues & Volume, By Service Type, 2022-2032 |
10.4 Africa Veterinary CRO CDMO Market, Revenues & Volume, By Drug Development Stage, 2022-2032 |
10.5 Africa Veterinary CRO CDMO Market, Revenues & Volume, By Animal Type, 2022-2032 |
10.6 Africa Veterinary CRO CDMO Market, Revenues & Volume, By Application, 2022-2032 |
10.7 Africa Veterinary CRO CDMO Market, Revenues & Volume, By End User, 2022-2032 |
11 Europe Veterinary CRO CDMO Market, Overview & Analysis |
11.1 Europe Veterinary CRO CDMO Market Revenues & Volume, 2022-2032 |
11.2 Europe Veterinary CRO CDMO Market, Revenues & Volume, By Countries, 2022-2032 |
11.2.1 United Kingdom Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
11.2.2 Germany Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
11.2.3 France Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
11.2.4 Rest of Europe Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
11.3 Europe Veterinary CRO CDMO Market, Revenues & Volume, By Service Type, 2022-2032 |
11.4 Europe Veterinary CRO CDMO Market, Revenues & Volume, By Drug Development Stage, 2022-2032 |
11.5 Europe Veterinary CRO CDMO Market, Revenues & Volume, By Animal Type, 2022-2032 |
11.6 Europe Veterinary CRO CDMO Market, Revenues & Volume, By Application, 2022-2032 |
11.7 Europe Veterinary CRO CDMO Market, Revenues & Volume, By End User, 2022-2032 |
12 Middle East Veterinary CRO CDMO Market, Overview & Analysis |
12.1 Middle East Veterinary CRO CDMO Market Revenues & Volume, 2022-2032 |
12.2 Middle East Veterinary CRO CDMO Market, Revenues & Volume, By Countries, 2022-2032 |
12.2.1 Saudi Arabia Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
12.2.2 UAE Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
12.2.3 Turkey Veterinary CRO CDMO Market, Revenues & Volume, 2022-2032 |
12.3 Middle East Veterinary CRO CDMO Market, Revenues & Volume, By Service Type, 2022-2032 |
12.4 Middle East Veterinary CRO CDMO Market, Revenues & Volume, By Drug Development Stage, 2022-2032 |
12.5 Middle East Veterinary CRO CDMO Market, Revenues & Volume, By Animal Type, 2022-2032 |
12.6 Middle East Veterinary CRO CDMO Market, Revenues & Volume, By Application, 2022-2032 |
12.7 Middle East Veterinary CRO CDMO Market, Revenues & Volume, By End User, 2022-2032 |
13 Global Veterinary CRO CDMO Market Key Performance Indicators |
14 Global Veterinary CRO CDMO Market - Export/Import By Countries Assessment |
15 Global Veterinary CRO CDMO Market - Opportunity Assessment |
15.1 Global Veterinary CRO CDMO Market Opportunity Assessment, By Countries, 2022 & 2032F |
15.2 Global Veterinary CRO CDMO Market Opportunity Assessment, By Service Type, 2022 & 2032F |
15.3 Global Veterinary CRO CDMO Market Opportunity Assessment, By Drug Development Stage, 2022 & 2032F |
15.4 Global Veterinary CRO CDMO Market Opportunity Assessment, By Animal Type, 2022 & 2032F |
15.5 Global Veterinary CRO CDMO Market Opportunity Assessment, By Application, 2022 & 2032F |
15.6 Global Veterinary CRO CDMO Market Opportunity Assessment, By End User, 2022 & 2032F |
16 Global Veterinary CRO CDMO Market - Competitive Landscape |
16.1 Global Veterinary CRO CDMO Market Revenue Share, By Companies, 2025 |
16.2 Global Veterinary CRO CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here